leon Secures Series B Funding to Accelerate Growth in Enabling Nano Now, While Establishing Strategic Partnership with Evotec
leon-nanodrugs GmbH, the leading enabler of nano technology for the pharmaceutical industry, announced today that it has successfullycompleted a Series B funding round. The capital will be used to further strengthen the company’s leadership position in the provision of nano solutions for the pharmaceutical and biotechnology industries.
Under a separate partnership agreement, Evotec and leon will leverage their combined expertise in nano-medicine development services, providing clients with world class, end to end opportunities within the CDMO sector. Together, the partnership will maximize the effectiveness of clinical and commercial nano-medicine development and co-operate on carefully selected development programs.
Andrea Cusack, CEO of leon commented “We are at the forefront of innovation in the international pharmaceutical market, leading the way in nano formulation of API’s. The strategic partnership with Evotec enables us to exploit the value of our technology and deliver a solution to clients from concept to GMP, successfully delivering products to market”
Dr Werner Lanthaler, Chief Executive Officer of Evotec, said: “We are excited about this new strategic collaboration with leon-nanodrugs. leon’s proprietary technology has the potential to be a game changer for the formulation, development and production of efficient drugs and will drive innovation efficiency by directly improving clinical outcomes. Our joint efforts in nanomedicine will ultimately benefit a large number of patients across a broad range of indications with significant unmet medical need.”
Christian Nafe, CFO of leon on the successful completion of the financing round: "We are encouraged by the positive participation of our new investors and the continued support of our existing consortium. This Series B funding will help us execute our strategy and bring products from the platform to the clinic.”
The investors come from right across the life sciences space, bringing a wealth of expertise and experience and includes TVM Life Science Innovation I.L.P., CD-Venture GmbH, Albany Private Equity Holdings Pty Ltd, Eckenstein-Geigy-Stiftung, LOF Leon Partnership, L.P., Evotec SE and BayBG.
Enno Spillner, CFO of Evotec and Dr. Peter Graf, Investment Manager of BayBG will join a peer recognized supervisory board which includes Dr. Hubert Birner (Managing Partner of TVM Life Science Venture Capital), Dr Gerhard Ries (LifeCare Partners), James C. Gale (Signet Healthcare Partners) and Dr. Frank Mathias (Rentschler Biotechnologie GmbH).
It is estimated that over 80% of pharmaceutical pipeline API’s are poorly soluble in water. Leon expedites Active Pharmaceutical Ingredients (APIs) to deliver improved stability, increased solubility and enhanced bioavailability, the benefits of which is lower dose, greater payload and faster onset. Leon’s novel validated and optimized solutions therefore create value for virtual companies and multinational Pharmaceutical organizations and ultimately provide better outcomes for patients.
About leon
leon delivers novel, validated and optimized solutions that create value for clients and provide better outcomes for their patients. It expedites API’s to deliver enhanced bioavailability, increased solubility and improved stability, revitalizing forgotten formulations, and breathing new life into generics.
leon’s proprietary* technology platforms offer access to the next generation of SMART nanoparticles™ and nano-formulated drugs, adding value at every stage of the chain from partners and payers to caregivers and patients.
* MicroJet Reactor (MJR)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200415005554/en/
Contact information
For more information
Andrea Cusack
CEO
leon-nanodrugs GmbH
T +49 (89) 41 42 488 981
E a.cusack@leon-nanodrugs.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
H.I.G. Capital Announces the Sale of DGS S.p.A.11.6.2024 12:00:00 CEST | Press release
H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $62 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell its portfolio company, DGS S.p.A. (“DGS” or the “Group”), a leading firm in the Italian Information Technology market, to DGS Co-Founders and management team in partnership with ICG, a global alternative asset manager. Since its inception in 1997, DGShas supported blue-chip customers in the design, integration, and maintenance of complex IT systems, with a specialization in digital transformation and cybersecurity services. The Group currently has over 1,900 employees, revenues of approximately €300 million, and maintains a group of highly loyal clientele. During H.I.G.’s ownership, DGS has tripled in size and consolidated its position as a leading Italian firm in cybersecurity services and digital transformation. DGS offers its clients sophisticated and proprietary digital transformation
Evertas Names Nick Selby Head of European Underwriting11.6.2024 12:00:00 CEST | Press release
Evertas, the world’s first crypto insurance company, has named Nick Selby as its new Head of European Underwriting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611141887/en/ Nick Selby, Executive Vice President and Head of European Underwriting at Evertas (Photo: Business Wire) Selby, an accomplished information and physical security professional, brings two decades of expertise in public and private sector information security, physical security, and complex incident handling, as well as seven years of experience leading teams securing billions of dollars in cryptoassets. Previously, his roles included VP of the Software Assurance Practice at Trail of Bits, Chief Security Officer at Paxos Trust Company, and Director of Cyber Intelligence and Investigations at the NYPD Intelligence Bureau. “Nick is an extremely valuable addition to our European team,” said Evertas CEO and Co-Founder J. Gdanski. “His public and private
Owlet utvider globalt fotavtrykk med lanseringen av medisinsk-sertifisert Dream Sock™ i Storbritannia og over hele Europa11.6.2024 11:00:00 CEST | Pressemelding
Owlet, Inc. («Owlet» or the «Company») (NYSE:OWLT), pioneren innen smart spedbarnsovervåking, kunngjør i dag den britiske og europeiske lanseringen av Dream Sock. Dette er en smart babymonitor med levende helseavlesninger og varsler for friske spedbarn mellom 0-18 måneder og 2,5-13,6 kg. Dette innovative medisinske utstyret gir foreldre helse og viktig informasjon i sanntid, noe som gir uovertruffen trygghet. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20240611820341/no/ (Photo: Business Wire) «Vi er svært stolte over å lansere Dream Sock til omsorgspersoner over hele Storbritannia og Europa og gi millioner av foreldre mer trygghet mens babyen sover,» sa Kurt Workman, Owlets administrerende direktør og medgründer. «Dream Sock er nå et globalt produkt som er anerkjent som medisinsk nøyaktig og trygt, etter å ha gjennomgått regulatoriske autorisasjoner og sertifiseringer innenfor flere geografier. I dag er misjonen vår
V-Nova Surpasses 1000 Patent Milestone in Media Technology Innovation11.6.2024 10:00:00 CEST | Press release
V-Nova, a leading provider of data compression solutions, video compression technology, XR technology, AI acceleration and parallel processing for a multitude of industries including media and entertainment, today announced its milestone achievement of 1000 active technology patents. This accomplishment underscores V-Nova’s dedication to research and development and its commitment to protecting its intellectual property globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611724561/en/ V-Nova’s patent portfolio spans more than 50 different jurisdictions. Including over 400 patents in Europe, over 200 in the Americas, over 100 in the United States specifically, and over 200 in Asia. V-Nova forged new directions in data processing to enhance digital experiences, maximize efficiency, reduce costs, and increase sustainability. The company leads the way with key international data compression standards for the video indust
Alipay+ Reveals Top Scorer Trophy Design for UEFA EURO 2024™11.6.2024 09:24:00 CEST | Press release
Alipay+, a suite of cross-border mobile payment and digitalization technology solutions operated by Ant International and an Official Partner of UEFA EURO 2024™, today revealed the trophy that will be awarded to the most prolific marksman at the UEFA EURO 2024™ finale on July 14 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240610328619/en/ The UEFA Top Scorer Trophy presented by Alipay+ is unveiled for UEFA EURO 2024™ (Photo: Business Wire) Sculpted in the shape of the Chinese character “支” (pronounced zhi, and meaning payment as well as support), the trophy reflects Alipay+’s dedication to supporting consumers to enjoy seamless payment and a broad choice of deals using their preferred payment methods while traveling abroad. The character also resembles the fleeting moment of a barefooted striker poised to shoot, evoking the original beauty and power of football – a game that united people across the wo